Neil Thomas is an angel investor based in Madrid, Spain with 8 known investments: RhoVac, BioXell S.p.A, Biobide SL, Genetrix Life Sciences AB, Orbit Genomics, Pharmacellion, Sensia SL and ZipPrime.
Is Neil Thomas a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Seed
- Sector
- Healthcare
Contacts
Neil Thomas portfolio companies (8)
- RhoVac
- BioXell S.p.A
- Biobide SL
- Genetrix Life Sciences AB
- Orbit Genomics
- Pharmacellion
- Sensia SL
- ZipPrime
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Digital Health, Intellectual Property and Medical Technologies. Startups operating in these areas may find Neil Thomas relevant.
Neil Thomas appears in Seed rounds across the known deals.
The portfolio and focus above give founders context on whether Neil Thomas matches their raise.
Similar investors
Showing 20 of 100
Frequently asked questions
Who is Neil Thomas?
Neil Thomas is an angel investor based in Madrid, Spain with 8 known investments on file, among them RhoVac, BioXell S.p.A and Biobide SL. The sections above list the sectors and stages attached to that record.
What does Neil Thomas invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Digital Health, Intellectual Property and Medical Technologies. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Neil Thomas invest at?
The known deals of Neil Thomas include Seed rounds. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
How do I contact Neil Thomas?
An email address, a phone number and a LinkedIn page are on file for Neil Thomas. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal
